Genetic testing, prevention and health insurance markets.

Summary Given the focus of this special issue of Medicine/Science on personalized medicine, it seems unnecessary for two economists to attempt to summarize or comment from a medical perspective on the advances and innovations that have characterized genetics research over the past two decades. Instead, we will focus on the implications of advances in genetic research on health insurance markets, their functioning and the levels of coverage they offer to individuals under the current regulations. More precisely, we will address the central theme of the value of information in a first section, while in a second section, we will study how the different effects that make up this value of information decline according to the regulations in force in the health insurance markets.